CD34 and chronic kidney disease: While technical differences between studies can make comparisons difficult, it is reassuring to note that our results are in line with a previous study in CKD patients, which demonstrated that CD34+ cells accounted for 0.05–0.14 % of all PBMCs (compared to 0.14 % of all PBMCs in our study) [61].